Insight into the dazzling impact of insulin in cells

MEDIA RELEASE: 21 May 2013 Garvan scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes. The breakthrough study is now published in the early online edition of the prestigious journal Cell Metabolism. More

Garvan and St Vincent’s Welcome Critical Prostate Cancer Funding for The Kinghorn Cancer Centre

MEDIA RELEASE: 17 May 2013 Both the Garvan Institute of Medical Research and St Vincent’s Hospital have welcomed the Federal Government’s foreshadowed announcement in this week’s budget of $5.5 million over 4 years to The Kinghorn Cancer Centre’s National Prostate Cancer Research Centre. More

Garvan and Cancer Therapeutics CRC Pty Ltd License Pan-Kinase Binding Agent to SYNkinase

MEDIA RELEASE: 16 May 2013 Garvan and Cancer Therapeutics CRC Pty Ltd have signed a licence agreement with SYNkinase Pty Ltd to develop and market a unique Pan-Kinase Binding Agent to help screen human cells and tissues and identify potential drug targets in diseased states. The novel agent has the unique ability to detect a large proportion of the protein kinase family, giving it the potential to become a remarkable research tool for life scientists around the globe. More

Evidence that brains re-wire themselves following damage or injury

MEDIA RELEASE: 14 May 2013 Neuroscientists from Garvan, in collaboration with learning theorists from the University of California Los Angeles (UCLA), have advanced our understanding of brain plasticity by showing that the brain forms complex new circuits after damage, often far from the damaged site, to compensate for lost function. This is the first demonstration of such circuit plasticity. More

John Schubert becomes Chairman of Garvan

MEDIA RELEASE: 01 May 2013 The Garvan Institute of Medical Research is delighted to announce the appointment this week of Dr John Schubert AO to its Board by the Governor of New South Wales, Her Excellency Professor Marie Bashir AC CVO, and his subsequent election by the Board as its Chair. He succeeds Mr Bill Ferris AC, Garvan Chairman since 2001. More

The connection between faulty neural activation and schizophrenia

MEDIA RELEASE: 28 Apr 2013 By studying what happens in the normal brain when neurons fire, Australian scientists have been able to identify a finely and dynamically regulated process. They also describe how dysfunction of this process is associated with schizophrenia. The process involves a specific class of genes known as ‘long non-coding RNAs’. More

Obesity may explain reduced bone fracture worldwide

MEDIA RELEASE: 10 Apr 2013 A Garvan study shows that women – but not men – with more abdominal fat are less at risk of bone fracture. This may explain why global rates of fracture are declining at the same time as obesity is increasing. The data come from the ongoing Dubbo Osteoporosis Epidemiology Study (DOES). More

Forget about plaque when diagnosing Alzheimer’s Disease

MEDIA RELEASE: 02 Apr 2013 A Garvan study has shown that plaque, long considered to be the hallmark of Alzheimer’s disease, is one of the last events to occur in the Alzheimer’s brain. This finding will impact the current debate about how best to diagnose and treat Alzheimer’s disease. More